VNDA Key Stats
- Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech C... May 23
- Nasdaq stocks posting largest percentage increases May 20
- Unusual 11 Mid-Day Movers 05/17: (RSOL) (SCTY) (VNDA) Higher; (ARUN) (UNXL) (COS... May 17
- UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17 Street Insider May 17
- Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17 Street Insider May 17
- Vanda Pharmaceuticals price target raised to $17 from $11 at Lazard Capital May 17
- Nasdaq stocks posting largest percentage increases May 16
- Nasdaq stocks posting largest volume increases May 15
- Stocks Hitting 52-Week Highs Benzinga May 13
- Jefferies Lifts PT on Vanda Pharmaceuticals (VNDA) to $7 Street Insider May 10
VNDA Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Vanda Pharmaceuticals is up 75.12% over the last year vs S&P 500 Total Return up 28.33%, Oramed Pharmaceuticals down 97.13%, and Stemline Therapeutics up 4.35%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for VNDA
Pro Report PDF for VNDA
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download VNDA Pro Report PDF
Pro Strategies Featuring VNDA
Did Vanda Pharmaceuticals make it into our Pro Portfolio Strategies?